[HTML] springer.comFull View

[HTML][HTML] High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou, X Zhang… - Journal of translational …, 2013 - Springer
Background This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …
被引用次数：41 相关文章
[HTML] nih.gov

[HTML][HTML] High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou, X Zhang… - Journal of …, 2013 - ncbi.nlm.nih.gov
Background This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …

High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou… - Journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Background This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …
[PDF] researchgate.net

[PDF][PDF] High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou, X Zhang, X Zhang… - 2013 - researchgate.net
Background: This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …

High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR.

F Wang, S Fu, Q Shao, YB Zhou… - Journal of …, 2013 - search.ebscohost.com
Background: This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …

High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR.

F Wang, S Fu, Q Shao, YB Zhou, X Zhang… - Journal of …, 2013 - europepmc.org
Background This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …
[PDF] core.ac.uk

[PDF][PDF] High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou, X Zhang, X Zhang… - 2013 - core.ac.uk
Background: This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …
[HTML] biomedcentral.com

[HTML][HTML] High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou… - Journal of …, 2013 - … -medicine.biomedcentral.com
This study was designed to determine whether advanced non-small-cell lung cancer
(NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) can …
[PDF] cyberleninka.org

[PDF][PDF] High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou, X Zhang, X Zhang… - 2013 - cyberleninka.org
Background: This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …
[PDF] psu.edu

[PDF][PDF] High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR

F Wang, S Fu, Q Shao, YB Zhou, X Zhang, X Zhang… - 2013 - Citeseer
Background: This study was designed to determine whether advanced non-small-cell lung
cancer (NSCLC) patients with high copy number of epidermal growth factor receptor (EGFR) …